BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5776421)

  • 1. Designing a parenteral manufacturing facility.
    Goddard KR
    Bull Parenter Drug Assoc; 1969; 23(2):69-77. PubMed ID: 5776421
    [No Abstract]   [Full Text] [Related]  

  • 2. Design control and validation of a facility for sterile clinical trial preparations.
    Staines L
    J Parenter Sci Technol; 1984; 38(3):109-14. PubMed ID: 6747778
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of clean room design on product contamination.
    Whyte W
    J Parenter Sci Technol; 1984; 38(3):103-8. PubMed ID: 6747777
    [No Abstract]   [Full Text] [Related]  

  • 4. Design and operation of a new sterile manufacturing facility.
    Fornabaio TA
    Bull Parenter Drug Assoc; 1970; 24(3):110-8. PubMed ID: 5422900
    [No Abstract]   [Full Text] [Related]  

  • 5. Designing and monitoring a sterility test facility.
    Stapert EM
    Bull Parenter Drug Assoc; 1972; 26(3):129-38. PubMed ID: 5035117
    [No Abstract]   [Full Text] [Related]  

  • 6. Facility for small volume parenteral manufacturing.
    Kelly PC
    Bull Parenter Drug Assoc; 1976; 30(2):72-9. PubMed ID: 949564
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bacterial content control and study of aseptic procedure in preparation of infusion solutions].
    Bábik I; Sagáth J
    Pharm Prax; 1968; 2():34-7. PubMed ID: 5731460
    [No Abstract]   [Full Text] [Related]  

  • 8. Designing a biological electron microscopy laboratory.
    Willis RA
    Med Biol Illus; 1969 Apr; 19(2):82-8. PubMed ID: 5777876
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hygienic problems in designing special boarding schools].
    Genesskaia RI
    Gig Sanit; 1967 Jun; 32(6):45-8. PubMed ID: 4236780
    [No Abstract]   [Full Text] [Related]  

  • 10. Designing a modern home for the elderly.
    Sabatino JS
    J Long Term Care Adm; 1979; 7(2):29-39. PubMed ID: 10243209
    [No Abstract]   [Full Text] [Related]  

  • 11. [Quality control of infusion solutions. I. Foreign particles in infusion solutions].
    van den Bemd AA
    Pharm Weekbl; 1969 Sep; 104(39):1205-9. PubMed ID: 5345140
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term care design: what you need to know about designing life-enhancing environments.
    Childs M; Grape TH; Webb-Johnson A; Wojciechowski A
    J Healthc Des; 1997; 9():121-4. PubMed ID: 10539135
    [No Abstract]   [Full Text] [Related]  

  • 13. Practical solutions: designing for improved human performance.
    Cunningham G; Millay KM
    J Healthc Des; 1997; 9():101-4. PubMed ID: 10539130
    [No Abstract]   [Full Text] [Related]  

  • 14. Parenteral manufacturing in hospitals.
    Turco SJ
    Bull Parenter Drug Assoc; 1975; 29(6):313-5. PubMed ID: 1203609
    [No Abstract]   [Full Text] [Related]  

  • 15. Compatibility guide for combining IV medications.
    Ng PK
    Am J Nurs; 1979 Jul; 79(7):1292-5. PubMed ID: 256451
    [No Abstract]   [Full Text] [Related]  

  • 16. ASHP--hospital intravenous admixture program certification.
    Turco S
    Hosp Pharm; 1978 Jun; 13(6):306, 356. PubMed ID: 10307642
    [No Abstract]   [Full Text] [Related]  

  • 17. [Special problems in the development of modern infusion solutions].
    Frank P
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1970 Mar; 40(3):77-88. PubMed ID: 5467832
    [No Abstract]   [Full Text] [Related]  

  • 18. Designing for life. Provider LifeSpace Award winners offer blueprint for success.
    Gilbert L
    Provider; 1997 Apr; 23(4):22-3, 25-6, 29-30. PubMed ID: 10166331
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous drug incompatibilities.
    Morris ME
    Am J Nurs; 1979 Jul; 79(7):1288-91. PubMed ID: 36757
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality assurance in I.V. admixture programs.
    Turco SJ
    Hosp Pharm; 1979 Jun; 14(6):307, 311-3. PubMed ID: 10242204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.